felin
virus
particularli
opportunist
charact
order
adapt
solitari
way
life
ancestr
felid
pathogen
acquir
elabor
mean
persist
within
host
popul
cours
time
infect
new
host
upon
rare
contact
individu
evolutionarili
assur
effici
transmiss
strategi
induct
latent
chronic
andor
asymptomat
infect
often
kept
multicat
household
place
catteri
shelter
today
domest
cat
consequ
particularli
suscept
viral
infect
close
proxim
high
social
contact
rate
anim
differ
vaccin
state
stress
environ
increas
risk
infect
moreov
strong
antigen
variabl
sever
common
felin
virus
includ
felin
caliciviru
fcv
felin
coronaviru
fcov
felin
leukemia
viru
felv
support
escap
immun
respons
lower
efficaci
current
avail
vaccin
avail
complementari
prophylact
strategi
could
help
protect
pet
cat
environ
high
infecti
pressur
long
diseas
andor
death
caus
infect
fatal
virus
promis
addit
vaccin
manipul
innat
immun
innat
pathogen
recognit
reli
set
sensori
molecul
tolllik
receptor
tlr
enabl
immedi
reaction
specif
immun
cell
pathogen
danger
signal
socal
pathogenassoci
molecular
pattern
pamp
due
abund
bacteri
well
viral
genom
oligodeoxynucleotid
odn
contain
unmethyl
cpg
motif
effect
recogn
pamp
vertebr
innat
immun
system
respons
cpg
odn
stimul
confer
express
mainli
intracellular
compart
human
b
cell
plasmacytoid
dendrit
cell
pdc
alarm
initi
instig
gene
express
profil
strongli
support
antivir
mechan
upregul
costimulatori
molecul
major
histocompat
complex
mhc
ii
surfac
stimul
cell
provid
stronger
antigen
present
potenti
product
cytokin
type
interferon
ifn
interleukin
il
tumor
necrosi
factor
tnf
contribut
provid
optim
immun
environ
develop
innat
adapt
respons
intracellular
pathogen
probabl
import
antivir
properti
cpg
odn
resid
potenti
stimul
product
high
amount
type
ifn
pdc
famili
cytokin
includ
shown
consider
enhanc
natur
killer
nk
cell
cytotox
promot
differenti
matur
immunostimulatori
function
monocyt
dc
induc
b
cell
product
immunoglobulin
thelper
th
differenti
cell
moreov
upon
bind
ubiquit
distribut
receptor
type
ifn
effect
induc
synthesi
variou
intracellular
protein
interfer
replic
broad
rang
virus
myxovirusresist
protein
mx
gtpase
wellstudi
exampl
intracellular
antivir
effector
enzym
known
directli
regul
type
ifn
detect
readili
use
marker
upregul
biolog
activ
cytokin
famili
distinct
class
odn
shown
induc
differenti
immun
respons
class
cpg
odn
cpga
consist
cpg
motif
phosphodiest
core
flank
end
phosphorothio
poli
g
sequenc
cpg
odn
class
character
potenti
induc
massiv
type
ifn
secret
pdc
increas
nk
cytotox
render
ideal
candid
prophylact
enhanc
innat
immun
viral
infect
convers
class
b
cpg
odn
cpgb
encod
multipl
cpg
motif
phosphorothio
backbon
promot
monocyt
matur
b
cell
activ
thu
substanti
support
develop
humor
immun
respons
cpga
cpgb
indic
immunostimulatori
properti
immun
cell
mice
primat
mani
domest
speci
vitro
vivo
studi
outbr
anim
mainli
carri
cpgb
concern
cat
specif
synthes
cpga
molecul
recent
shown
induc
cpgb
molecul
indic
capabl
induc
prolifer
felin
cell
cpgbadjuv
allergen
indic
potenti
immunotherapi
felin
asthma
model
although
class
c
class
p
odn
develop
recent
year
effort
combin
advantag
effect
cpga
cpgb
increas
immunogen
cpga
remain
strongest
induc
type
ifn
describ
date
potenti
cpg
odn
prophylact
standalon
induc
innat
defens
mechan
subject
studi
work
field
initi
describ
protect
mice
bacteri
parasit
infect
recent
induct
resist
viral
infect
shown
also
mous
model
herp
simplex
viru
neurotrop
arenaviru
foot
mouth
diseas
viru
vaccinia
viru
except
latter
studi
carri
cpgb
outbr
speci
partial
antivir
protect
describ
two
studi
far
reduc
shed
herp
parainfluenza
virus
observ
lamb
administr
also
cpgb
knowledg
prophylact
antivir
potenti
cpga
yet
describ
outbr
anim
carri
seri
experi
object
character
immunomodulatori
antivir
properti
cpga
domest
cat
vitro
prototyp
cpga
odn
strengthen
antivir
qualiti
felin
immun
cell
stimul
product
solubl
molecul
inhibit
replic
five
differ
famili
virus
coronavirida
herpesvirida
calicivirida
parvovirida
retrovirida
vivo
odn
induc
system
antivir
state
fourteen
male
castrat
spf
cat
divid
four
differ
age
group
use
studi
group
week
group
year
group
year
group
year
cat
group
origin
litter
individu
relat
vivo
experi
conduct
cat
year
age
anim
purchas
liberti
research
inc
waverli
ny
usa
spf
statu
verifi
previous
describ
studi
carri
strict
accord
regul
swiss
law
anim
protect
sr
veterinari
offic
swiss
canton
zurich
offici
revis
protocol
approv
studi
permit
tvb
tvb
anim
hous
group
animalfriendli
barrier
facil
optim
etholog
condit
blood
collect
inject
cat
sedat
combin
ketamin
midazolam
possibl
effort
made
minim
stress
suffer
felin
pbmc
isol
edtaanticoagul
whole
blood
ficollhypaqu
densiti
gradient
centrifug
use
standard
protocol
purifi
cell
count
prior
util
differ
experi
use
sysmex
xt
sysmex
norderstedt
germani
describ
previous
cultur
rpmi
glutamax
invitrogen
basel
switzerland
adher
crfk
atcc
fea
cell
maintain
rpmi
glutamax
adher
cell
atcc
cultur
emem
atcc
media
supplement
heatinactiv
fetal
calf
serum
bioconcept
allschwil
switzerland
uml
penicillin
mgml
streptomycin
invitrogen
odn
odn
obtain
alexi
biochem
enzo
life
scienc
ag
switzerland
vitro
studi
odn
synthes
microsynth
ag
balgach
switzerland
vivo
experi
recombin
felin
obtain
pbl
biomed
piscataway
new
jersey
usa
molecul
solubil
endotoxinfre
pb
odn
consist
sequenc
odn
cpg
motif
invers
gpc
vitro
experi
odn
dilut
rpmi
glutamax
supplement
describ
viabil
stimul
cell
compar
use
trypan
blue
exclus
test
briefli
stimul
h
increas
concentr
odn
odn
equival
volum
pb
control
cell
stain
trypan
blue
solut
dr
bender
dr
hobein
ag
zurich
switzerland
percentag
viabl
cell
compar
pbmc
seed
immedi
isol
concentr
cellsml
ubottom
plate
triplic
cultur
cat
treat
either
odn
equal
volum
endotoxinfre
pb
initi
incub
h
cell
puls
h
hthymidin
perkin
elmer
schwerzenbach
switzerland
standard
liquid
scintil
protocol
use
harvest
cell
uptak
h
assess
packard
tricarb
liquid
scintil
analyz
perkin
elmer
prolifer
rate
calcul
mean
count
per
minut
cpm
triplic
cultur
stimul
index
si
depict
figur
calcul
follow
mean
cpmof
odntreat
culturesmean
cpm
pbstreat
cultur
pbmc
treat
densiti
cellsml
odn
odn
equival
volum
endotoxinfre
pb
cultur
h
format
collect
cell
adher
cell
fraction
remov
trypsinedta
invitrogen
harvest
cell
divid
fraction
label
separ
either
antifelin
mous
monoclon
igg
kindli
provid
prof
mari
tompkin
flow
cytometri
cell
sort
laboratori
nc
state
colleg
veterinari
medicin
usa
antifelin
mhcii
mous
monoclon
depart
patholog
microbiolog
immunolog
univers
california
davi
usa
fluoresceinisothiocyan
fitc
conjug
mous
isotyp
control
bd
bioscienc
allschwil
swizerland
fraction
subsequ
stain
rphycoerythrin
rpe
conjug
goat
antimous
bioconcept
allschwil
swizerland
fluoresc
data
obtain
use
instrument
becton
dickinson
allschwil
switzerland
softwar
gate
repres
lymphocyt
nonlymphocyt
popul
set
basi
forward
versu
side
scatter
total
event
acquir
nonlymphocyt
gate
data
analyz
flowjo
softwar
tree
star
olten
switzerland
wherebi
addit
gate
set
compris
lymphocyt
nonlymphocyt
popul
pbmc
gate
mhcii
express
level
determin
mean
fluoresc
intens
gate
cell
popul
ident
gate
set
cat
way
compris
desir
cell
popul
anim
pbmc
stimul
odn
odn
endotoxinfre
pb
densiti
cellsml
directli
isol
crfk
fea
cell
cultur
confluenc
prior
stimul
experi
carri
format
stimul
adher
cell
supernat
product
see
total
cell
cultur
medium
discard
well
monolay
cultur
undilut
supernat
rest
experi
time
point
relev
experi
supernat
remov
cell
lyse
mrna
lysi
buffer
mrna
isol
kit
roch
diagnost
rotkreuz
switzerland
mrna
extract
perform
mrna
isol
kit
magna
pure
lc
instrument
roch
diagnost
first
strand
cdna
synthes
high
capac
cdna
revers
transcript
kit
appli
biosystem
rotkreuz
switzerland
realtim
quantit
pcr
qpcr
reaction
consist
cdna
total
volum
per
reaction
use
fast
univers
pcr
master
mix
appli
biosystem
thermocycl
condit
includ
initi
denatur
follow
cycl
amplif
melt
anneal
primer
probe
felin
gene
previous
describ
mrna
express
factor
select
gene
correspond
ratio
mrna
level
measur
odn
odn
stimul
versu
pb
stimul
cell
calcul
normal
genorm
version
use
either
felin
gusb
tryptophan
activ
protein
zeta
polypeptid
ywhaz
usual
glyceraldehyd
dehydrogenas
gapdh
alon
specifi
refer
gene
condit
valid
felin
speci
gener
depict
graph
mean
express
factor
calcul
duplic
experi
carri
simultan
result
one
cat
illustr
experi
conduct
cell
least
individu
anim
repres
data
shown
cat
pbmc
resuspend
supplement
rpmi
glutamax
invitrogen
concentr
cellsml
plate
stimul
immedi
isol
odn
odn
equival
volum
endotoxinfre
pb
h
incub
supernat
harvest
centrifug
cultur
twice
g
min
aliquot
store
larg
supernat
quantiti
produc
pbmc
purifi
one
blood
collect
enabl
util
supernat
viru
inhibit
experi
concern
vsv
fcv
fcov
fhv
fpv
new
supernat
batch
produc
use
felv
inhibit
assay
supernat
deriv
pbmc
stimul
odn
odn
endotoxinfre
pb
refer
sup
sup
neg
text
figur
crfk
grown
confluenc
plate
stimul
pbmc
supernat
produc
explain
time
point
indic
cell
harvest
count
cell
either
cell
line
resuspend
sampl
buffer
tri
hydroxymethyl
aminomethan
sd
glycerol
bromphenol
blue
boil
min
sdspage
separ
submers
immunoblot
procedur
carri
previous
describ
spectra
multicolor
broad
rang
protein
ladder
fermenta
gmbh
st
leonrot
germani
serv
molecular
weight
standard
marker
blot
protein
visual
membran
first
cut
immedi
marker
band
top
bottom
membran
fraction
incub
murin
antihuman
mx
mab
gener
provid
dr
j
pavlov
institut
virolog
univers
switzerland
murin
monoclon
antibodi
load
control
sigma
aldrich
gmbh
buch
switzerland
respect
fraction
subsequ
incub
peroxidaselabel
goat
antimous
igg
jackson
immunoresearch
newmarket
suffolk
uk
band
digit
use
chemigeniu
bioimag
system
syngen
cambridg
uk
vsv
indiana
strain
institut
virolog
vetsuiss
faculti
univers
zurich
switzerland
fcov
wellcom
strain
gener
gift
prof
kipar
univers
liverpool
great
britain
fpv
kindli
provid
prof
u
truyen
univers
leipzig
germani
fhv
strain
fcv
strain
kindli
provid
veterinaria
ag
zurich
switzerland
titrat
crfk
cell
viral
stock
dilut
induc
cytopath
effect
cpe
h
h
fcov
fpv
select
inhibit
experi
order
ensur
proper
measur
inhibitori
effect
monolay
crfk
cell
plate
incub
h
supernat
produc
pbmc
cat
group
except
assay
carri
fpv
viral
inhibit
experi
conduct
simultan
supernat
thaw
equal
number
time
treat
cell
inocul
viru
vsv
fcv
fhv
fcov
trypsin
trypsinedta
invitrogen
allow
settl
viral
suspens
fpv
inhibit
assay
carri
h
h
fcov
fpv
accord
procedur
describ
previous
briefli
supernat
discard
cell
debri
remov
well
cycl
wash
hank
balanc
salt
solut
hbss
gibco
invitrogen
shake
orbit
shaker
remain
cell
fix
formalin
stain
crystal
violet
solut
spectrophotometr
measur
methanol
ad
dri
well
absorb
read
nm
spectramax
plu
microtit
plate
reader
molecular
devic
bucher
biotec
ag
basel
switzerland
viral
inhibit
rate
calcul
follow
formula
mean
optic
densityodvalu
duplic
well
treat
supernatantmean
od
valu
quadrupl
well
treat
medium
alon
felva
strain
gener
gift
prof
hosi
jarret
univers
glasgow
great
britain
titrat
fea
cell
lowest
stock
dilut
lead
product
infect
cell
h
use
inhibit
assay
experi
carri
plate
cell
treat
supernat
relev
control
immedi
prior
inocul
everi
second
day
thereaft
cultur
medium
replac
volum
fresh
supernat
appropri
time
point
cell
supernat
harvest
total
nucleic
acid
extract
cell
supernat
use
magna
pure
lc
dna
isol
kit
magna
pure
lc
instrument
roch
diagnost
viral
replic
supernat
provir
load
cell
measur
realtim
rtpcr
realtim
pcr
respect
assay
previous
describ
time
cours
experi
conduct
supernat
deriv
pbmc
three
cat
measur
day
post
inocul
carri
materi
deriv
two
addit
cat
order
facilit
interpret
figur
illustr
measur
viral
rna
load
cyclescycl
threshold
ct
valu
calcul
mean
duplic
well
depict
cat
administ
odn
subcutan
dose
mgkg
bodi
weight
cat
receiv
endotoxinfre
pb
control
treatment
distribut
equal
portion
bilater
axillari
inguin
region
heparin
blood
collect
time
point
h
inject
treatment
h
h
h
h
h
cat
clinic
examin
bodi
temperatur
measur
time
point
whole
blood
sampl
use
part
assess
hematolog
paramat
sysmex
xt
sysmex
norderstedt
germani
previous
describ
rest
blood
mix
mrna
lysi
buffer
roch
diagnost
immedi
upon
blood
collect
process
recommend
manufactur
plasma
obtain
centrifug
whole
blood
sampl
min
g
conserv
use
vitro
experi
mx
mrna
express
measur
qpcr
normal
express
two
felin
housekeep
gene
describ
express
factor
depict
figur
repres
ratio
mrna
level
specif
time
point
mrna
level
time
point
h
viral
inhibit
assay
plasma
collect
cat
time
point
incub
h
cell
prior
inocul
fcv
assay
carri
describ
viral
inhibit
factor
calcul
follow
mean
optic
densityodvalu
duplic
well
treat
plasma
od
valu
duplic
well
treat
plasma
timepoint
xh
statist
analyz
perform
use
graphpad
prism
window
version
graphpad
softwar
san
diego
california
usa
due
limit
number
cat
integr
studi
refrain
use
parametr
approach
statist
test
test
requir
larger
sampl
size
n
possibl
calcul
pvalu
induct
express
gene
shown
figur
differ
treatment
group
prolifer
pbmc
analyz
test
express
costimulatori
molecul
surfac
cell
analyz
wilcoxon
sign
rank
test
valu
cat
pair
rel
mx
mrna
express
od
valu
viral
inhibit
assay
ratio
felv
proviru
ct
valu
felv
viral
rna
load
analyz
wilcoxon
sign
rank
test
pair
valu
cat
treatment
differ
supernat
compar
test
incub
supernat
oppos
treatment
medium
alon
normal
rel
mrna
express
ratio
differ
anim
age
group
also
compar
test
longitudin
effect
felv
viral
provir
load
compar
use
test
carri
area
curv
auc
valu
correl
assess
use
spearman
test
pvalu
consid
statist
signific
prolifer
pbmc
respons
treatment
cpg
odn
give
strong
indic
biolog
activ
stimulatori
molecul
use
screen
odn
mani
speci
relat
potenti
cpga
induc
prolifer
felin
pbmc
assess
measur
hthymidin
incorpor
stimul
although
consider
variabl
observ
individu
increas
prolifer
observ
stimul
odn
compar
stimul
inact
control
odn
p
figur
cell
three
cat
could
stimul
particularli
high
prolif
rate
odn
valu
mean
eight
cat
illustr
figur
follow
order
anoth
characterist
featur
stimulatori
odn
abil
enhanc
interact
variou
immun
cell
popul
upregul
cell
surfac
costimulatori
molecul
object
test
whether
odn
could
exert
properti
felin
immun
cell
express
mhcii
measur
flow
cytometri
stimul
pbmc
eight
cat
express
costimulatori
molecul
evalu
gate
defin
contain
pbmc
popul
lymphocyt
popul
nonlymphocyt
popul
cell
observ
effect
vari
consider
cell
individu
cat
rang
alter
increas
stain
cell
cellular
subpopul
odn
stimul
also
anim
stimul
control
odn
indic
similar
stain
pattern
pb
wherea
cat
induct
effect
compar
odn
could
observ
respons
cell
origin
particular
cat
stimul
odn
howev
correl
influenc
odn
express
either
surfac
molecul
cell
overal
increas
express
mhcii
measur
gate
pbmc
upon
h
stimul
odn
overlaid
express
molecul
odn
pb
stimul
figur
c
consid
eight
cat
lymphocyt
cell
express
significantli
higher
level
mhcii
expos
odn
treatment
pb
p
p
respect
figur
f
felin
mhcii
express
lymphocyt
also
seem
affect
odn
odn
similar
manner
figur
nonlymphocyt
cell
odn
specif
affect
express
molecul
induc
signific
upregul
surfac
level
molecul
compar
stimul
odn
p
pb
p
h
figur
contrast
express
mhcii
significantli
alter
cell
gate
nonlymphocyt
time
point
stimul
figur
final
cell
three
cat
exhibit
highest
prolifer
rate
respons
odn
figur
also
indic
strongest
increas
express
cell
surfac
molecul
cellular
subpopul
test
interact
cpga
typic
induc
express
type
ifn
proinflammatori
cytokin
stimul
cell
order
understand
whether
odn
exert
similar
effect
cat
treat
cultur
felin
pbmc
fea
crfk
cell
systemat
screen
increas
mrna
express
follow
stimul
although
test
immort
felin
cell
line
express
mrna
data
shown
fail
respond
stimul
odn
figur
b
data
shown
howev
molecul
exhibit
potent
immunomodulatori
properti
felin
pbmc
measur
h
post
stimul
concentr
odn
suffici
enhanc
transcript
maximum
induct
gene
observ
odn
use
figur
although
affect
similar
pattern
mrna
express
proinflammatori
cytokin
remain
compar
low
concentr
test
figur
experi
foreseen
determin
gene
express
kinet
felin
cell
stimul
odn
molecul
influenc
transcript
could
measur
earli
h
treatment
pbmc
wherea
increas
level
mrna
observ
h
post
stimul
figur
f
notabl
highest
induct
gene
measur
h
addit
odn
cultur
transcript
increas
time
point
respect
figur
f
observ
effect
specif
confer
cpg
motif
compris
odn
sinc
specif
control
odn
induc
slight
elev
express
gene
test
figur
importantli
trypan
blue
exclus
experi
indic
evid
cellular
toxic
treatment
neither
odn
odn
concentr
test
data
shown
effort
assess
breadth
effect
confer
treatment
cpga
possibl
variabl
respons
obtain
individu
cat
mrna
express
ten
gene
relev
earli
immun
respons
measur
odn
stimul
pbmc
fourteen
cat
divid
four
differ
age
group
group
week
n
group
year
n
group
year
n
group
year
n
slight
individu
variabl
gene
induct
observ
h
stimul
immun
cell
adult
cat
rang
year
age
figur
overal
mrna
express
profil
measur
stimul
pbmc
cat
corrobor
induct
strong
antivir
immun
respons
express
type
ifn
mrna
includ
substanti
increas
immun
cell
subject
odn
stimul
everi
adult
cat
minim
induct
respect
observ
older
anim
group
figur
moreov
individu
subtyp
test
induc
similar
level
cell
four
adult
cat
group
figur
increas
level
proinflammatori
cytokin
mrna
also
measur
individu
group
systemat
increas
cell
cat
indic
typic
orient
stimul
enhanc
transcript
anim
togeth
absent
low
induct
stimul
pbmc
odn
also
creat
optim
environ
nk
cell
activ
indic
increas
mrna
express
nk
cell
stimul
nk
cell
effector
granzym
b
cell
cat
effect
prolifer
figur
andor
exhibit
strongest
express
costimulatori
molecul
figur
follow
odn
stimul
also
consist
express
highest
mrna
level
granzym
b
pbmc
cat
group
figur
also
far
respons
stimul
odn
cell
kitten
group
stimul
higher
individu
variabl
observ
adult
anim
figur
pbmc
cat
group
could
stimul
odn
increas
mrna
express
test
gene
individu
mrna
express
type
ifn
gene
enhanc
much
lower
level
observ
adult
cat
overal
immun
respons
favor
direct
character
upregul
downregul
mrna
level
figur
order
determin
whether
discrep
express
pbmc
adult
anim
kitten
could
play
role
observ
mrna
level
gene
measur
immun
cell
cat
although
basal
express
similar
pbmc
cat
age
group
figur
odn
stimul
increas
transcript
cell
kitten
decreas
transcript
gene
cell
adult
cat
differ
mrna
level
receptor
significantli
higher
young
cat
group
adult
cat
group
p
figur
protect
properti
type
ifn
virus
origin
abil
trigger
product
potent
antivir
protein
nearbi
cell
express
one
antivir
protein
mx
gtpase
known
directli
stimul
type
ifn
use
marker
induct
intracellular
antivir
mechan
cytokin
cat
well
speci
thu
detect
felin
type
ifn
protein
level
render
difficult
unavail
antibodi
specif
recogn
protein
mrna
level
mx
measur
felin
pbmc
stimul
odn
indic
product
type
ifn
transcript
mx
significantli
enhanc
remain
proport
mrna
express
type
ifn
stimul
pbmc
individu
cat
figur
moreov
peak
level
mx
mrna
measur
h
stimul
cell
indic
presenc
optim
effect
type
ifn
present
cell
cultur
medium
time
point
figur
order
determin
potenti
type
ifn
liber
odn
stimul
pbmc
induc
intracellular
antivir
mechan
nonimmun
target
cell
cellfre
supernat
pbmc
deriv
blood
individu
adult
cat
stimul
vitro
h
odn
odn
endotoxinfre
pb
sup
sup
sup
neg
respect
incub
crfk
cell
mx
gene
transcript
significantli
enhanc
cell
treat
sup
compar
sup
p
sup
neg
p
level
compar
achiev
stimul
cell
recombin
felin
figur
data
shown
sup
deriv
cell
individu
anim
shown
particularli
strong
respons
odn
previou
experi
also
induc
highest
mx
mrna
express
cell
line
test
although
treatment
sup
systemat
increas
mx
transcript
target
cell
protein
level
remain
low
figur
data
shown
furthermor
peak
induct
mx
transcript
observ
cell
line
alreadi
within
hour
incub
sup
figur
data
shown
protein
level
achiev
maximum
level
within
h
post
stimul
remain
stabl
thereaft
least
anoth
h
figur
data
shown
felid
frequent
affect
four
virus
differ
famili
felin
herpesviru
fhv
caliciviru
fcv
parvoviru
fpv
coronaviru
fcov
although
virus
product
infect
purifi
pbmc
vitro
share
abil
induc
cytopath
effect
cpe
crfk
cell
felin
cell
line
howev
alter
mrna
level
gene
select
marker
innat
immun
upon
direct
treatment
odn
figur
b
data
shown
prevent
assess
potenti
molecul
inhibit
viral
replic
directli
cell
thu
crfk
cell
incub
prior
inocul
cellfre
supernat
pbmc
mention
sup
sup
sup
neg
aim
supernat
deriv
pbmc
treat
h
select
sup
produc
cell
sever
adult
cat
estim
contain
optim
type
ifn
amount
time
point
accord
induct
mx
transcript
measur
directli
immun
cell
figur
crfk
target
cell
incub
supernat
h
inocul
time
span
indic
highest
induct
antivir
mechan
figur
antivir
effect
supernat
initi
test
vesicular
stomat
viru
vsv
control
viru
wide
recogn
potenti
induc
cpe
cell
line
multipl
speci
particularli
high
sensit
effect
type
ifn
sup
deriv
pbmc
eight
adult
cat
broadli
respond
vitro
odn
stimul
figur
c
group
incub
cell
prior
inocul
signific
inhibit
vsv
replic
observ
p
figur
replic
viru
also
degre
repress
sup
p
observ
reminisc
slight
induct
mx
target
cell
incub
supernat
figur
turn
propag
fcv
fcov
fhv
fpv
cell
also
significantli
suppress
sup
compar
sup
p
p
p
p
respect
sup
neg
p
howev
expect
lower
sensit
vsv
figur
tabl
sup
sup
neg
fail
inhibit
replic
heterogen
group
felin
virus
underlin
essenti
role
molecul
confer
observ
effect
importantli
cell
stimul
odn
directli
indic
resist
viral
replic
concord
impair
respons
molecul
alreadi
measur
genet
level
figur
b
data
shown
respect
younger
cat
sup
kitten
whose
cell
respond
odn
stimul
figur
group
could
also
inhibit
vsv
fcv
cell
supernat
deriv
pbmc
kitten
indic
inhibit
potenti
virus
figur
l
altogeth
viral
suppress
potenti
sup
cat
could
compar
confer
treatment
cell
quantiti
determin
titrat
experi
conduct
togeth
viral
inhibit
assay
data
shown
differenti
inhibit
virus
test
supernat
reflect
distinct
viral
inhibit
ratio
observ
figur
tabl
sensit
viru
correl
sensit
sup
induct
mx
target
cell
supernat
highli
correl
inhibit
virus
figur
final
sup
deriv
pbmc
cat
whose
cell
indic
strong
respons
stimul
odn
previou
experi
effici
inhibit
replic
virus
similar
result
notabl
obtain
supernat
pbmc
deriv
cat
incub
crfk
cell
prior
inocul
abovement
virus
data
shown
cell
line
previous
indic
less
sensit
antivir
effect
type
ifn
gener
higher
amount
found
titrat
experi
requir
inhibit
five
virus
concordantli
averag
fold
viral
inhibit
crfk
cell
sup
approxim
half
observ
cell
life
cycl
retrovirus
character
revers
transcript
genom
rna
dna
subsequ
integr
viral
dna
proviru
genom
host
caus
perman
infect
often
accompani
persist
viru
product
infect
cell
felin
leukemia
viru
felv
gammaretroviru
propag
fea
cell
vitro
affect
domest
cat
worldwid
viral
replic
chronic
infect
cat
lower
treatment
potenti
sup
produc
pbmc
five
adult
cat
group
group
inhibit
product
infect
fea
cell
analyz
initi
experi
cell
line
exhibit
similar
respons
crfk
cell
direct
treatment
odn
incub
differ
supernat
figur
data
shown
compar
incub
medium
alon
treatment
fea
cell
sup
h
prior
inocul
felv
follow
repetit
treatment
cell
supernat
everi
day
thereaft
significantli
reduc
viral
rna
p
dna
p
measur
cell
cultur
supernat
cell
respect
day
post
inocul
figur
b
antivir
potenti
supernat
individu
cat
similar
howev
best
result
confer
sup
deriv
cell
depict
figur
b
kinet
curv
viral
rna
load
cultur
cell
treat
sup
cat
similar
obtain
cell
treat
data
shown
also
treatment
cell
odn
directli
affect
neither
viral
rna
viral
dna
load
measur
supernat
cell
respect
data
shown
mx
mrna
express
higher
sup
treat
cell
control
day
post
inocul
indic
abil
supernat
sustain
antivir
mechan
appli
cell
repeatedli
figur
furthermor
time
point
sup
treat
cell
exhibit
significantli
lower
viral
dna
load
p
produc
significantli
less
viru
p
cell
treat
sup
sup
neg
medium
alon
figur
e
extent
mx
transcript
confer
sup
cat
strongli
correl
lower
proviru
p
viru
p
load
measur
fea
cell
supernat
respect
day
post
inocul
p
also
highest
mx
mrna
level
target
cell
confer
sup
cat
reflect
lowest
viral
provir
load
measur
time
point
experi
final
step
induct
antivir
respons
odn
measur
vivo
character
use
ex
vivo
assay
molecul
administ
subcutan
two
cat
two
cat
receiv
endotoxinfre
pb
neg
control
inject
well
toler
cat
rise
bodi
temperatur
local
reaction
inject
site
undesir
side
effect
note
absolut
monocyt
count
increas
first
h
cat
receiv
odn
data
shown
treatmentspecif
alter
note
hematolog
valu
throughout
experi
mx
express
measur
blood
earli
time
point
inject
marker
induct
antivir
immun
process
mrna
level
mx
increas
within
h
treat
cat
decreas
gradual
thereaft
h
post
treatment
figur
accord
observ
vitro
experi
cat
exhibit
stronger
respons
odn
cat
increas
mx
express
observ
blood
control
cat
experi
plasma
collect
four
cat
regular
interv
post
inject
util
vitro
inhibit
assay
plasma
obtain
treat
cat
h
administr
molecul
abl
inhibit
replic
fcv
vitro
figur
contrast
plasma
untreat
cat
seem
slightli
enhanc
suscept
target
cell
fcv
inocul
present
studi
conduct
vitro
vivo
experi
character
immunomodulatori
antivir
effect
cpga
molecul
domest
cat
show
odn
first
describ
cpga
upregul
express
seri
gene
felin
immun
cell
play
import
role
earli
respons
virus
solubl
molecul
produc
felin
pbmc
upon
odn
stimul
significantli
increas
resist
variou
felin
target
cell
line
propag
virus
five
differ
famili
name
fcv
fpv
fhv
fcov
felv
observ
repress
viral
replic
highli
correl
mrna
express
type
ifn
gene
stimul
pbmc
well
induct
prior
inocul
antivir
mechan
target
cell
furthermor
singl
administr
odn
significantli
increas
express
mx
blood
treat
cat
plasma
anim
could
also
inhibit
replic
fcv
vitro
data
underlin
prophylact
potenti
odn
outbr
speci
standalon
agent
larg
rang
viral
pathogen
simultan
cat
may
highli
benefit
molecul
place
environ
strong
infecti
pressur
catteri
shelter
pet
show
cell
felin
immun
system
strongli
influenc
cultur
presenc
odn
first
felin
pbmc
significantli
prolifer
presenc
odn
indic
direct
indirect
stimul
one
immun
cell
subpopul
molecul
although
contrast
class
odn
cpga
gener
induc
lymphocyt
prolifer
mice
similar
effect
previous
observ
ovin
cell
higher
concentr
cpga
could
induc
minim
level
prolifer
addit
odn
increas
express
cell
surfac
costimulatori
molecul
pbmc
reinforc
possibl
interact
variou
immun
cell
popul
subsequ
specif
respons
molecul
upregul
lymphocyt
nonlymphocyt
cell
odn
stimul
mhcii
express
could
increas
lymphocyt
cell
observ
may
link
time
point
measur
necess
transport
cell
surfac
mhcii
molecul
coupl
antigen
present
immun
cell
final
transcript
seri
marker
innat
immun
respons
consider
influenc
felin
pbmc
stimul
odn
astonish
effect
molecul
therebi
remain
potent
induct
mrna
express
gene
increas
respect
pbmc
certain
anim
line
observ
publish
recent
induct
cpg
odn
remain
moder
nevertheless
measur
carri
h
stimul
purifi
felin
cell
support
induct
immun
respons
enhanc
nk
cell
activ
highli
desir
context
viral
infect
variabl
immunomodulatori
antivir
effect
odn
felin
cell
mainli
relat
age
cat
among
middleag
adult
cat
consist
stimulatori
potenti
molecul
reflect
highli
similar
pattern
gene
express
profil
induc
immun
cell
stimul
well
moder
deviat
experi
aim
character
immunomodulatori
properti
odn
figur
cell
sever
anim
howev
particular
cat
also
indic
particularli
strong
respons
stimul
throughout
studi
observ
like
link
genet
variabl
individu
outbr
speci
inherit
factor
known
play
import
role
magnitud
innat
immun
respons
respect
observ
note
spf
origin
mainten
barrier
facil
anim
includ
studi
may
slightli
lower
variabl
strength
breadth
innat
immun
respons
studi
cell
obtain
field
cat
would
give
inform
diverg
respons
stimul
innat
immun
cell
individu
anim
immun
cell
cat
year
age
seem
respond
slightli
less
well
odn
younger
adult
anim
pbmc
kitten
indic
much
retic
stimul
either
limit
absent
upregul
type
ifn
gene
measur
incub
odn
stimul
pbmc
group
young
anim
moreov
indic
tendenc
develop
immunolog
environ
orient
includ
higher
product
impair
induct
compar
cell
adult
cat
although
kitten
includ
studi
alreadi
week
age
observ
strongli
corrobor
immatur
ifn
system
neonat
mice
impair
immun
cell
activ
via
human
neonat
mononuclear
cell
bia
toward
rather
respons
human
fetus
neonat
furthermor
concordantli
find
human
neonat
blood
basal
transcript
kitten
indic
level
similar
adult
howev
odn
stimul
increas
mrna
express
gene
young
anim
figur
result
open
new
perspect
possibl
explan
qualit
discrep
innat
immun
respons
newborn
adult
avail
specif
antibodi
felin
would
greatli
support
investig
direct
experi
conduct
vitro
vivo
studi
underlin
feasibl
util
mx
marker
induct
resist
viral
infect
domest
cat
admittedli
supernat
pbmc
stimul
cpga
serum
treat
cat
contain
mixtur
molecul
could
play
role
observ
antivir
effect
howev
viral
inhibit
vitro
assay
similar
obtain
treatment
cell
highli
correl
induct
mx
transcript
cell
line
incub
supernat
odn
inject
vivo
mx
express
plasma
also
strongli
correl
antivir
potenti
howev
import
note
mx
mrna
protein
mechanist
link
inhibit
virus
test
although
express
antivir
molecul
synthetas
oa
rnadepend
protein
kinas
pkr
measur
induct
report
follow
cpg
odn
stimul
pbmc
speci
differenti
interplay
sever
effector
mechan
like
lead
inhibit
individu
virus
comparison
odn
group
cpga
use
much
fewer
studi
concern
innat
antivir
respons
like
result
time
consum
costli
manufactur
process
molecul
link
synthesi
flank
poli
g
string
necessari
optim
immun
effect
also
cpga
exhibit
weak
stimul
b
cell
produc
antibodi
valuabl
later
antivir
respons
stabil
cpga
vivo
also
question
due
partial
phosphorothio
backbon
molecul
partial
compens
howev
format
associ
poli
g
stretch
highli
order
gtetrad
structur
enhanc
stabil
smaller
content
synthet
backbon
could
moreov
help
reduc
possibl
longterm
side
effect
importantli
cpga
remain
potent
induc
type
ifn
biolog
activ
antivir
molecul
known
date
regard
recombin
felin
type
ifn
market
japan
europ
virbagen
made
way
therapeut
protocol
fcv
fhv
felv
canin
parvoviru
infect
demonstr
prevent
capac
catteri
develop
outbreak
fpv
howev
compar
direct
initi
antivir
mechan
recombin
protein
administr
cpg
odn
hold
advantag
induc
product
type
ifn
subtyp
shown
possess
differenti
antivir
properti
kinet
data
demonstr
five
viral
speci
belong
caliciviru
herpesviru
parvoviru
coronaviru
retroviru
famili
highli
sensit
immunolog
effect
odn
felin
cell
strength
breadth
antivir
defens
mechan
induc
vivo
molecul
potenti
outweigh
observ
recombin
ifn
frame
result
vitro
experi
administr
odn
vivo
could
promot
antivir
state
domest
cat
absenc
advers
reaction
stimul
pbmc
exhibit
high
mrna
express
type
ifn
margin
increas
mrna
level
proinflammatori
cytokin
treat
cat
show
significantli
increas
mx
express
blood
lack
flulik
symptom
gener
link
administr
immunostimulatori
molecul
vivo
addit
although
vivo
studi
includ
limit
number
cat
strength
respons
odn
stimul
vitro
vivo
individu
anim
strongli
correl
indic
individu
sensit
stimul
like
predict
vitro
experi
data
show
singl
subcutan
inject
odn
suffic
induc
system
presenc
antivir
molecul
h
plasma
treat
cat
time
increas
mx
express
least
blood
treat
cat
indic
signific
inhibit
viral
replic
vitro
observ
support
possibl
resist
viral
infect
odn
sever
day
phenomenon
describ
alreadi
mous
model
altogeth
studi
underlin
strong
potenti
odn
prevent
larg
varieti
viral
diseas
cpga
molecul
thu
left
asid
stimul
innat
immun
prophylact
purpos
futur
studi
aim
optim
kinet
molecul
vivo
address
safeti
stabil
manufactur
issu
combin
adjuv
tlr
agonist
well
optim
administr
protocol
support
research
direct
field
studi
larger
cohort
anim
provid
insight
util
cpga
molecul
prevent
viral
infect
clinic
set
author
declar
compet
interest
crt
hl
conceiv
design
project
hl
supervis
studi
crt
vlr
perform
experi
analyz
data
support
vc
mlm
mf
br
respons
hous
care
spf
cat
well
organ
blood
collect
enabl
work
vesicular
stomat
viru
rhl
mf
mt
pm
provid
crucial
reagent
materi
andor
analysi
tool
well
valuabl
recommend
util
author
critic
revis
manuscript
approv
final
version
